QS Investors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-16,148
| Closed | -$848K | – | 1292 |
|
|
2020
Q3 | $848K | Sell |
16,148
-88,000
| -84% | -$3.64M | 0.01% | 493 |
|
|
2020
Q2 | $3.47M | Sell |
104,148
-5,800
| -5% | -$185K | 0.05% | 304 |
|
|
2020
Q1 | $2.99M | Sell |
109,948
-56,135
| -34% | -$1.56M | 0.05% | 297 |
|
|
2019
Q4 | $3.21M | Sell |
166,083
-2,446
| -1% | -$39.1K | 0.03% | 425 |
|
|
2019
Q3 | $2.19M | Hold |
168,529
| – | – | 0.02% | 536 |
|
|
2019
Q2 | $2.1M | Sell |
168,529
-3,938
| -2% | -$52.3K | 0.02% | 575 |
|
|
2019
Q1 | $2.51M | Hold |
172,467
| – | – | 0.03% | 508 |
|
|
2018
Q4 | $1.91M | Hold |
172,467
| – | – | 0.02% | 568 |
|
|
2018
Q3 | $4.54M | Hold |
172,467
| – | – | 0.04% | 311 |
|
|
2018
Q2 | $3.53M | Buy |
172,467
+19
| +0% | +$408 | 0.03% | 411 |
|
|
2018
Q1 | $3.13M | Sell |
172,448
-11,592
| -6% | -$193K | 0.03% | 416 |
|
|
2017
Q4 | $2.57M | Sell |
184,040
-8,143
| -4% | -$110K | 0.02% | 517 |
|
|
2017
Q3 | $3.56M | Sell |
192,183
-4,006
| -2% | -$67K | 0.03% | 419 |
|
|
2017
Q2 | $3.32M | Sell |
196,189
-1,993
| -1% | -$30.3K | 0.03% | 432 |
|
|
2017
Q1 | $2.65M | Sell |
198,182
-983
| -0.5% | -$15.4K | 0.02% | 519 |
|
|
2016
Q4 | $3M | Sell |
199,165
-77,893
| -28% | -$1.03M | 0.02% | 498 |
|
|
2016
Q3 | $3.24M | Hold |
277,058
| – | – | 0.03% | 517 |
|
|
2016
Q2 | $2.99M | Hold |
277,058
| – | – | 0.03% | 539 |
|
|
2016
Q1 | $2.56M | Buy |
277,058
+977
| +0.4% | +$10.5K | 0.02% | 586 |
|
|
2015
Q4 | $4.1M | Buy |
276,081
+209,681
| +316% | +$3.51M | 0.04% | 459 |
|
|
2015
Q3 | $1.09M | Buy |
66,400
+32,000
| +93% | +$655K | 0.01% | 757 |
|
|
2015
Q2 | $785K | Buy |
+34,400
| New | +$685K | 0.01% | 802 |
|
QS Investors's MNTA Position: Q4 2020 in Review
QS Investors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 16,148 shares — an estimated $848K sold.
QS Investors first reported a position in MNTA in Q2 2015 and held it in 22 quarters. The position peaked at $4.54M in Q3 2018. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- QS Investors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- QS Investors sold 16,148 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $848K.
- QS Investors first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2015 and held it in 22 quarters.
- QS Investors's Momenta Pharmaceuticals, Inc. position peaked at $4.54M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on QS Investors's 13F filing for Q4 2020, filed 10 Feb 2021.